CA2653952A1 - Use of protein satb2 as a marker for colorectal cancer - Google Patents

Use of protein satb2 as a marker for colorectal cancer Download PDF

Info

Publication number
CA2653952A1
CA2653952A1 CA002653952A CA2653952A CA2653952A1 CA 2653952 A1 CA2653952 A1 CA 2653952A1 CA 002653952 A CA002653952 A CA 002653952A CA 2653952 A CA2653952 A CA 2653952A CA 2653952 A1 CA2653952 A1 CA 2653952A1
Authority
CA
Canada
Prior art keywords
satb2
affinity ligand
colo
sample
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002653952A
Other languages
English (en)
French (fr)
Inventor
Mathias Uhlen
Fredrik Ponten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlas Antibodies AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2653952A1 publication Critical patent/CA2653952A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002653952A 2006-06-02 2007-06-04 Use of protein satb2 as a marker for colorectal cancer Abandoned CA2653952A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06114954.8 2006-06-02
EP06114954A EP1862803A1 (en) 2006-06-02 2006-06-02 Use of protein SATB2 as a marker for colorectal cancer
US81661306P 2006-06-27 2006-06-27
US60/816,613 2006-06-27
PCT/EP2007/004931 WO2007140966A1 (en) 2006-06-02 2007-06-04 Use of protein satb2 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
CA2653952A1 true CA2653952A1 (en) 2007-12-13

Family

ID=36968849

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002653952A Abandoned CA2653952A1 (en) 2006-06-02 2007-06-04 Use of protein satb2 as a marker for colorectal cancer

Country Status (11)

Country Link
US (3) US8067190B2 (enExample)
EP (3) EP1862803A1 (enExample)
JP (2) JP4990970B2 (enExample)
CN (2) CN103293307B (enExample)
AT (2) ATE514090T1 (enExample)
AU (1) AU2007256391B2 (enExample)
CA (1) CA2653952A1 (enExample)
DK (2) DK2024747T3 (enExample)
ES (1) ES2367412T3 (enExample)
PL (1) PL2211180T3 (enExample)
WO (1) WO2007140966A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100662821B1 (ko) * 2006-04-05 2006-12-28 유니트마 주식회사 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2107375A1 (en) * 2008-03-31 2009-10-07 Atlas Antibodies AB Uses of WARS protein in cancer prognostics
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
EP2396657B1 (en) * 2009-02-16 2013-11-13 Atlas Antibodies AB Rbm3 as a marker for malignant melanoma prognosis
CA2948548C (en) * 2014-05-13 2022-06-28 Vastcon Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosis
US11326210B2 (en) * 2015-01-30 2022-05-10 Glax Llc Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
US20160258438A1 (en) * 2015-03-05 2016-09-08 Regal Beloit America, Inc. Assembly, blower and associated method
WO2016176446A2 (en) * 2015-04-29 2016-11-03 Geneoscopy, Llc Colorectal cancer screening method and device
WO2018081580A1 (en) 2016-10-27 2018-05-03 Geneoscopy, Llc Detection method
CN106841131A (zh) * 2016-12-29 2017-06-13 上海交通大学 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用
CA3136405A1 (en) 2018-06-01 2019-12-05 Geneoscopy, Inc. Detection method for cancer using rna biomarkers
US20210262041A1 (en) * 2018-08-08 2021-08-26 Indian Institute Of Science Education And Research Combined expression pattern of satb family chromatin organizers as improved biomarker tool for cancer prognosis
US12435335B2 (en) 2022-06-06 2025-10-07 Cornell University Promoting nutrient absorption through the colon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
WO2003022126A2 (en) * 2001-08-21 2003-03-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
DE102004037860A1 (de) 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
US7932032B2 (en) * 2005-05-02 2011-04-26 Toray Industries, Inc. Method for diagnosing esophageal cancer
GB2435882A (en) 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer

Also Published As

Publication number Publication date
US20120270956A1 (en) 2012-10-25
US20090220975A1 (en) 2009-09-03
US8465934B2 (en) 2013-06-18
CN103293307A (zh) 2013-09-11
ATE514090T1 (de) 2011-07-15
ATE513216T1 (de) 2011-07-15
JP2012073260A (ja) 2012-04-12
CN101460850A (zh) 2009-06-17
US20120028836A1 (en) 2012-02-02
EP2024747A1 (en) 2009-02-18
DK2024747T3 (da) 2011-09-19
WO2007140966A1 (en) 2007-12-13
DK2211180T3 (da) 2011-09-26
JP4990970B2 (ja) 2012-08-01
EP1862803A1 (en) 2007-12-05
EP2211180B1 (en) 2011-06-22
US8067190B2 (en) 2011-11-29
PL2211180T3 (pl) 2011-11-30
JP2009539082A (ja) 2009-11-12
EP2024747B1 (en) 2011-06-15
AU2007256391A1 (en) 2007-12-13
AU2007256391B2 (en) 2011-05-19
ES2367412T3 (es) 2011-11-03
EP2211180A1 (en) 2010-07-28
CN103293307B (zh) 2016-03-23
US8241859B2 (en) 2012-08-14
JP5301630B2 (ja) 2013-09-25

Similar Documents

Publication Publication Date Title
AU2007256391B2 (en) Use of protein SATB2 as a marker for colorectal cancer
EP2396346B1 (en) Rbm3 protein in colorectal cancer prognostics
EP2318841B1 (en) Anln protein as an endocrine treatment predictive factor
EP2107375A1 (en) Uses of WARS protein in cancer prognostics
AU2009213167B2 (en) RBM3 as a marker for breast cancer prognosis
US8420788B2 (en) Epitopes derived from SATB2 and uses thereof
EP2055717A1 (en) Prognostic method
EP2241889A1 (en) RBM3 protein in colorectal cancer prognostics

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20170227